Available Until 2/8/2025
View Cart

Optimizing Patient Safety: Guidance for the Safe Use of Parenteral Nutrition in Adult and Pediatric Patients

ACPE Activity Number:   0204-0000-23-413-H05-P
Content Release Date: February 8, 2024
Expiration Date: February 8, 2025
Activity Type: Application-based   
CE Credits: 1.5 contact hours (0.15 CEUs)
Activity Fee: Free

Activity Overview

Concern over drug shortages remains a topic of concern nationwide. This educational activity will review strategies for ensuring safe and effective therapy for adult and pediatric patients when parenteral nutrition (PN) components are in short supply. The activity will also review current and upcoming guidelines that relate to optimizing PN therapy for adult and pediatric patients. The activity will conclude with clinical cases that illustrate best practices in PN therapy, including lipid injectable emulsion (ILE) dosing, in adult and pediatric patients.

*Please note, this activity was presented live on December 4, 2023 as part of the ASHP 2023 Midyear Clinical Meeting & Exhibition. You can only claim credit once for this activity; live or home study

ACPE Provider with Commendation logo
The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education with Commendation.

This activity was planned to meet the educational needs of pharmacists involved with parenteral nutrition in hospitals and health systems.

After participating in this CPE activity, learners should be able to:

  • Analyze strategies for ensuring safe, effective therapy for adult and pediatric patients when parenteral nutrition (PN) components are in short supply.
  • Apply current guidelines and recommendations to the care of adult and pediatric patients receiving PN.
  • Develop a treatment plan including patient-specific factors and best practices when selecting lipid injectable emulsion (ILE) formulations for adult and pediatric patients. 

Phil Ayers, PharmD, BCNSP, FMSHP, FASHP, Activity Chair
Chief, Clinical Pharmacy Services - Baptist Medical Center
Clinical Associate Professor - University of Mississippi School of Pharmacy
Jackson, Mississippi



More information on Phil Ayers
Phil Ayers, PharmD, BCNSP, FMSHP, FASHP, is a clinical specialist in nutrition support at Baptist Medical Center in Jackson, Mississippi and serves the Department of Pharmacy as Chief of Clinical Pharmacy Services. Dr. Ayers also serves as Clinical Associate Professor with the School of Pharmacy at the University of Mississippi. He received his Bachelor of Science and Doctor of Pharmacy degree from the University of Mississippi. He currently serves the American Society for Parenteral and Enteral Nutrition (ASPEN) on the Board of Directors as President-Elect and is Past Chair of the ASPEN Parenteral Nutrition Safety Committee. Phil is a member of the USP Compounding Committee and Chair of the Parenteral Nutrition Subcommittee. Dr. Ayers was awarded the ASPEN Excellence in Nutrition Support Education Award, 2011 and the ASPEN. Stanley Serlick Award for Parenteral Nutrition Safety in 2016.

 

Angela Bingham, PharmD, BCCCP, BCNSP, BCPS, FASHP, FASPEN, FCCM, FCCP
Acting Chair and Clinical Associate Professor
Philadelphia College of Pharmacy, Saint Joseph's University
Critical Care/Nutrition Support Clinical Pharmacy Specialist
Cooper University Health Care
Philadelphia, Pennsylvania



More information on Angela Bingham

Angela Bingham, PharmD, BCCCP, BCNSP, BCPS, FASHP, FASPEN, FCCM, FCCP is Acting Chair, Clinical Associate Professor, PGY2 Critical Care Pharmacy Residency Program Director, and Residency Programs Coordinator within the Department of Pharmacy Practice at the Philadelphia College of Pharmacy, Saint Joseph's University. She practices as a Critical Care/Nutrition Support Clinical Pharmacy Specialist at Cooper University Health Care in Camden, New Jersey. Dr. Bingham is board certified in nutrition support, critical care, and pharmacotherapy. She is a Fellow of the American Society for Parenteral and Enteral Nutrition, American Society of Health-System Pharmacists, American College of Clinical Pharmacy, and Society of Critical Care Medicine. Professional contributions have included: Chair, Board of Pharmacy Specialties Specialty Council on Nutrition Support Pharmacy; Chair, ASHP Council on Education and Workforce Development; Content Matter Expert, ASHP Critical Care Pharmacy Review and Recertification Program; Faculty, ACCP Teaching and Learning Academy Program; Chair, ASPEN Pharmacy Practice Section as well as task forces for adult critical care nutrition guideline revisions, parenteral nutrition appropriateness consensus recommendations, and standards of practice for nutrition support pharmacists. She is an Associate Editor for Nutrition in Clinical Practice and Assistant Editor for DiPiro's Pharmacotherapy: A Pathophysiologic Approach. 

In accordance with our accreditor’s Standards of Integrity and Independence in Accredited Continuing Education, ASHP requires that all individuals in control of content disclose all financial relationships with ineligible companies. An individual has a relevant financial relationship if they have had a financial relationship with an ineligible company in any dollar amount in the past 24 months and the educational content that the individual controls is related to the business lines or products of the ineligible company. 

An ineligible company is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The presence or absence of relevant financial relationships will be disclosed to the activity audience.

The following persons in control of this activity’s content have relevant financial relationships:

  •          Phil Ayers – Fresenius Kabi: Consultant, Speaker’s bureau; Baxter: Speaker’s bureau
  •          Angela Bingham – Abbott Nutrition Health Institute: Speaker's bureau

All other persons in control of content do not have any relevant financial relationships with an ineligible company. As defined by the Standards of Integrity and Independence in Accredited Continuing Education definition of ineligible company. All relevant financial relationships have been mitigated prior to the CE activity. 

To receive CE credit, complete the steps below within 60 days of completing the activity.

  1.        View the entire presentation and answer all polling questions.
  2.        Click "Complete Activity" on last slide then complete the evaluation to claim credit. 
  3.        Verify credits were successfully transferred to CPE Monitor before the ACPE 60-day deadline by checking your NABP eProfile account.

Per ACPE requirements, CPE credit must be claimed within 60 days of being earned – no exceptions! To verify that you have completed the required steps and to ensure your credits have been reported to CPE Monitor, we encourage you to check your NABP eProfile account to validate your credits were transferred successfully before the ACPE 60-day deadline. After the 60 day deadline, ASHP will no longer be able to award credit for this activity.

Provided by ASHP
Supported by an educational grant from Fresenius Kabi USA, LLC